Tumor-specific activity of precision medicines in the NCI-MATCH trial.
Ivvone ZhouDeborah PlanaAdam C PalmerPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
These findings support the value of basket trials because even when precision medicines do not have tumor-agnostic activity, basket trials can identify tumor-specific activity for future study.